#objectiveresponserate

Amgen’s lung cancer treatment gets conditional approval - PharmaTimes IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer

#oncology #lungcancer @amgen.bsky.social #lungcancertreatment #IMDYLLTRA #tarlatamab #extensivestagesmallcelllungcancer #ESSCLC #ESSCLCpatients #UK #MHRA #conditionalmarketingauthorisation #Smallcelllungcancer #SCLC #DeLLphi301study #objectiveresponserate
pharmatimes.com/news/amgens-...